Italia markets close in 3 hours 11 minutes

Johnson & Johnson (JNJ)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
157,96+2,19 (+1,41%)
Alla chiusura: 04:00PM EDT
157,80 -0,16 (-0,10%)
Preborsa: 09:18AM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente155,77
Aperto155,99
Denaro157,69 x 800
Lettera158,00 x 800
Min-Max giorno155,44 - 158,22
Intervallo di 52 settimane144,95 - 175,97
Volume8.373.625
Media Volume7.131.095
Capitalizzazione380,649B
Beta (5 anni mensile)0,53
Rapporto PE (ttm)30,38
EPS (ttm)5,20
Prossima data utili16 apr 2024
Rendimento e dividendo (futuro)4,76 (3,01%)
Data ex dividendo16 feb 2024
Stima target 1A162,68
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA